DetoxiGenomic®
Profile
DetoxiGenomic® Profile evaluates single nucleotide
polymorphisms (SNPs) associated with increased risk
of impaired detoxification capacity especially when
exposed to environmental toxins. The test also identifies
individuals potentially susceptible to adverse drug
reactions. The test uncovers potential genetic susceptibility
to:
• Adverse Drug Reactions
• Numerous Cancers
• Neurodegenerative Disorders
• Mood Disorders
• Fatigue Syndromes
• Fibromyalgia
• Multiple Chemical Sensitivity
• Oxidative Stress |
|
OsteoGenomic™
Profile
Osteogenomic™ Profiles evaluates genetic variations,
called single nucleotide polymorphisms (SNPs), in genes
that modulate bone formation (collagen synthesis), bone
breakdown (resorption), and inflammation, including
key regulatory mechanisms affecting calcium and Vitamin
D3 metabolism. The test uncovers potential genetic susceptibility
to:
• Low Bone Mineral Density
• Osteoporosis
• Osteopenia
• Age-Related Bone Fractures
• Arthritis |
| |
|
|
| |
|
|
| |
|
|
NeuroGenomic™
Profile
NeuroGenomic™ Profile evaluates single nucleotide
polymorphisms (SNPs) in Genes that modulate methylation,
glutathione conjugation, oxidative protecition (and
potential to evaluate vascular oxidation). The test
uncovers potential genetic susceptibility to:
• Neurodegenerative Disorders
• Developmental Issues
• Mood Disorders
• Oxidative Stress
• Detoxification Capacity
|
|
CardioGenomic®
Profile
CardioGenomic® Profile evaluates genetic variations,
called single nucleotide polymorphisms (SNPs), in genes
that modulate blood pressure regulation, lipid balance,
nutrient metabolism, inflammation, and oxidative stress.
The test uncovers potential genetic susceptibility to:
• Hypercholesteremia
• Atherosclerosis
• Obesity
• Hypertension
• Coronary Artery Disease
• Myocardial Infarction
• Thromboses
• Endothelial Dysfunction
• Stroke
|
| |
|
|
| |
|
|
| |
|
|
CardioGenomicPlus™
Profile
CardioGenomic® Profile evaluates genetic variations,
called single nucleotide polymorphisms (SNPs), in genes
that modulate blood pressure regulation, lipid balance,
nutrient metabolism, inflammation, and oxidative stress.
The test uncovers potential genetic susceptibility to:
• Hypercholesteremia
• Atherosclerosis
• Obesity
• Hypertension
• Coronary Artery Disease
• Myocardial Infarction
• Thromboses
• Endothelial Dysfunction
• Stroke |
|
EstroGenomic™
Profile
EstroGenomic™ Profile evaluates genetic variations,
called single nucleotide polymorphisms (SNPs), in genes
that modulate estrogen metabolism, coagulation, cardiovascular
disease, and osteoporosis. The test uncovers potential
genetic susceptibility to:
• Breast Cancer
• Osteoporosis
• Thromboses
• Stroke
• Atherosclerosis
• Heart Disease |
| |
|
|
| |
|
|
| |
|
|
ImmunoGenomic™
Profile
ImmunoGenomic™ Profile evaluates genetic variations,
called single nucleotide polymorphisms (SNPs), in genes
that modulate immune and inflammatory activity. Polymorphisms
affect the levels and activity of the cytokines. These
variations can affect balance between cell(TH-1) and
hu,oral(TH-2) immunity, reveal potential defects in
immune system defense, and stimulate mechanisms lending
to chronic, overactive inflammatory responses. The test
uncovers potential genetic susceptibility to:
• Asthma
• Autoimmune Disorders
• Certain Cancers
• Allergy
• Infectious Diseases
• Bone Inflammation
• Arthritis
• Inflammatory Bowel Disease
• H. pylori (cause of ulcers)
• Heart Disease
• Osteopopenia |
|
|
| |
|
|
|
|
